Second primary malignancies after treatment for malignant lymphoma

British Journal of Cancer

Volumn 93, Issue 4, 2005, Pages 418-424

  Okines, A ^a   Thomson, C S ^b   Radstone, C R ^a   Horsman, J M ^a   Hancock, B W ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

^b Trent Cancer Registry   (United Kingdom)

Author keywords

Malignant lymphoma; Matched case control study; Second primary cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CHLORMETHINE; PREDNISONE; PROCARBAZINE; VINCRISTINE SULFATE;

ANUS CARCINOMA; ARTICLE; BILE DUCT CARCINOMA; BLADDER CARCINOMA; BRAIN TUMOR; BREAST CANCER; BRONCHUS CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART SARCOMA; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; SECOND CANCER; SKIN CANCER; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; CASE CONTROL STUDY; INCIDENCE; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

CASE-CONTROL STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RISK FACTORS;

EID: 24944474897     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602731     Document Type: Article

References (35)

1. Aisenberg AC, Finkestein DM, Doppke KP, Koerner FC, Boivin J-F, Willett CG (1997) High risk of breast cancer after irradiation of young women with Hodgkin's disease. Cancer 79(6): 1203-1210
2. Barista I, Cabanillas F, Ramoguera JE, Khouri IF, Yang Y, Smith TL, Strom SS, Medeiros LJ, Hagemeister FB (2002) Is there an increased rate of additional malignancies in patients with mantle cell lymphoma? Ann Oncol 13: 318-322
3. Boivin J-F, Hutchinson GB, Auber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CTC, Fuller LM, Mauch P, Ultmann JE (1995) Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87(10): 32-41
4. Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. Volume I - The Analysis of Case-Control Studies. Lyon: IARC Scientific Publication No. 32, International Agency for Research on Cancer
5. Canellos GP, DeVita VT, Arseneau JC, Whang-Peng J, Johnson REC (1975) Second malignancies complicating Hodgkin's disease in remission. Lancet 1: 947-949
6. Cimino G, Papa G, Tura P, Mazza P, Rossi Ferrini PL, Bosi A, Amadori S, La Coco F, D'Arcangelo E, Giannarelli D, Mandelli F (1991) Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. J Clin Oncol 9(3): 432-437
7. Connors JM (2003) Hodgkin's lymphoma: the hazards of success. J Clin Oncol 21: 3431-3439
8. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M, Travis LB (2002) Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 15: 3484-3494
9. Foss Abrahamsen J, Anderson A, Hannisdal E, Nome O, Foss Abrahamsen A, Kvaløy S, Høst H (1993) Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. J Clin Oncol 11(2): 255-261
10. Greene MH, Young RC, Merrill JM, DeVita VT (1983) Evidence of a treatment dose-response in acute non-lymphoblastic leukaemias which occur after therapy of NHL. Cancer Res 43: 1891-1898
11. Hancock BW (2003) Cancers induced by treatment of lymphoma. Lancet Oncol 4: 577-578
12. Hancock SL, Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85(1): 25-31
13. Henry-Amar M (2000) Long-term problems in malignant lymphoma. In Malignant Lymphoma, Hancock BW, Selby PJ, MacLennan K, Armitage JO (eds) pp 421-436. London: Arnold
14. Janjan NA, Wilson JF, Gillin N, Anderson T, Greenberg M, Schewe K, Cox JD (1988) mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 61: 252-254
15. Kaldor JM, Day NE, Clarke EA, van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pederson D, Band P, Assouline D, Koch M, Choi W, Prior P, Blair V, Langmark F, Pompe Kirn V, Neal F, Peters D, Pfeiffer R, Karjalainen S, Cuzick J, Sutcliffe SB, Somers R, Pellae-Cosset B, Pappagallo GL, Fraser P, Storm H, Stovall M (1990) Leukaemia following Hodgkin's disease. N Engl J Med 322(1): 7-13
16. Lavey RS, Eby NL, Prosnitz LR (1990) Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 66(1): 80-88
17. Micallef INM, Lillington DM, Apostolidis J, Amess JAL, Neat M, Matthews J, Clark T, Foran JM, Salam A, Lister TA, Rohatiner AZS (2000) Therapy-related myelodysplasia and secondary acute myelogenous leukaemia after high dose therapy with autologous haematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 18(5): 947-955
18. Moertal CG, Hagendorn AB (1957) Leukaemia or lymphoma and coexistent primary malignant lesions: a review of the literature and a study of 120 cases. Blood 12: 788-803
19. Pederson-Bjergaard J, Larsen SO (1982) Incidence of acute non-lymphocytic leukaemia, preleukaemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med 307(16): 965-971
20. Prior P, Pope DJ (1988) Hodgkin's disease: subsequent primary cancers in relation to treatment. Br J Cancer 58: 512-517
21. StataCorp. STATA statistical software (2001) Release 7.0. College Station. Texas: Stata Corporation
22. Stone RM (1994) Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress? Blood 83(12): 3437-3440
23. Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ (1997) Second malignancy in patients with Hodgkin's disease treated at the royal marsden hospital. Br J Cancer 75(1): 116-123
24. Swerdlow AJ, Barber JA, Vaughan Hudson G, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18: 498-509
25. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B, Bennett MH, MacLennan KA (1992) Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the british national lymphoma investigation. BMJ 304: 1137-1143
26. Swerdlow AJ, Schoemaker MJ, Allerton R, Horwich A, Barber JA, Cunningham D, Lister TA, Rohatiner AZS, Vaughan Hudson G, Williams MV, Linch DC (2001) Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol 19(6): 1610-1618
27. Travis LB, Curtis RE, Boice JD, Hankey BF, Fraumeni JF (1991) Second cancers following non-Hodgkin's lymphoma. Cancer 7: 2002-2009
28. Travis LB, Curtis RE, Glimelius B, Holowaty E, van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder F, Inskip P, Tucker MA, Fraumeni JF, Boice JD (1993) Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85(23): 1932-1937
29. Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD (1996) Leukaemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol 14(2): 565-571
30. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin's disease. N Eng J Med 318(2): 76-81
31. Tura S, Fiacchini M, Zinzani PL, Brusamolino E, Gobbi PG (1993) Splenectomy and the increasing risk of secondary acute leukaemia in Hodgkin's disease. J Clin Oncol 11(5): 925-930
32. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G (1986) Second acute leukaemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4(6): 830-837
33. van Leeuwen FE, Klokman WJ, Hagenbeek A, Nayan R, van den Belt-Dusebout AW, van Kerkhoff EHM, van Heerde P, Somers R (1994a) Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 12(2): 312-325
34. van Leeuwen FE, Chorus AMJ, van den Belt-Dusebout EHM, Hagenbeek A, Nayon R, van Kerkhoff EHM, Pinedo HM, Somers R (1994b) Leukaemia risk following Hodgkin's disease: relation to cumulative dose of alkylationg agents, treatment with teniposide combinations, number of episodes o chemotherapy, and bone marrow damage. J Clin Oncol 12(5): 1063-1073
35. van Leeuwen FE, Klockman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD, Burgers MV, Somers R (1995) Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87: 1530-1537